181817-14-1

Basic information

• Product Name: (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid
• Synonyms: (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid;O-Acetyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-threonine
• CAS NO: 181817-14-1
• Molecular Formula: C21H21NO6
• Molecular Weight: 383.39
• Mol File: 181817-14-1.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid(181817-14-1)
• EPA Substance Registry System: (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid(181817-14-1)

Safety Data

• Hazardous Substances Data: 181817-14-1(Hazardous Substances Data)

Usage

General Description

The chemical (2S,3R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-acetoxybutanoic acid is a compound with a complex structure that contains a fluorenyl group and an acetoxybutanoic acid moiety. It is an amino acid derivative with a specific stereochemistry (2S,3R). The presence of the fluorenyl group and the acetoxybutanoic acid suggest that this compound may have potential applications in medicinal chemistry, such as in the development of pharmaceutical drugs. Further research and analysis are needed to fully understand the properties and potential uses of this chemical.

Upstream product

• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 
• 17012-42-9 O-acetyl-L-threonine 
• 31077-89-1 1,3,4,6-tetra-O-acetyl-2-deoxy-2-fluoro-β-D-glucopyranose 
• 73731-37-0 Fmoc-Thr-OH 

Downstream Products

• 252049-06-2 N-Fmoc-N-methyl-L-threonine 
• 1353654-66-6 (2S,3R)-benzyl 2-methylamino-3-((triisopropylsilyl)oxy)butanoate 
• 1353654-76-8 (5S)-4-(benzyloxy)-1-methyl-5-{(1R)-1-[(triisopropylsilyl)oxy]ethyl}-1H-pyrrol-2(5H)-one 
• 17012-42-9 O-acetyl-L-threonine 

Relevant articles and documents

Synthesis, stereochemical assignment, and bioactivity of the Penicillium metabolites penicillenols B1 and B2

The Penicillium metabolites penicillenols B1 and B2 were synthesised for the first time by elimination of a mesylated penicillenol A precursor as obtained from an l-threonine derived tetramic acid. The (Z,S)- and (E,S)-configured diastereomers were identical to the natural compounds as to NMR spectra and optical rotations. Both isomers showed antiproliferative effects against cancer and endothelial cell lines and penicillenol B1 was also notably antibiotic against Staphylococcus aureus.